International Cannabinoid Derived Pharmaceutical Market data
International Cannabinoid Derived Pharmaceutical Market section
International Cannabinoid Derived Pharmaceutical market is valued at US$ 636.8 Million in 2021,and it’s anticipated to succeed in US$ 11.2 Billion by 2030, with CAGR of 37.7{aaa84efcd05d20dc7d0e48929bb8fd8c8895020217096fb46d833d790411cbb9}
— Insightace Analytic
NEW JERSEY, NJ, USA, August 19, 2022 /EINPresswire.com/ — InsightAce Analytic Pvt. Ltd. broadcasts the discharge of a market evaluation report on the “International Cannabinoid Derived Pharmaceutical Market- by Merchandise (Pure (Plant-derived) (Epidiolex, Sativex and Different Pipeline Merchandise), and Artificial Cannabinoid (Marinol (Dronabinol), Syndros (Dronabinol), Cesamet (Nabilone) and Different Pipeline Merchandise)), Molecule Kind (Cannabinoid Receptor Kind 1 (CB1), Cannabinoid Receptor Kind 2 (CB2), and Others), Illness Indication (Alzheimer’s Illness, Autism, Most cancers, Power Ache, Epilepsy, Migraine, A number of Sclerosis, Schizophrenia, and Others), Developments, Trade Competitors Evaluation, Income and Forecast To 2030.”
Request for Pattern Pages: https://www.insightaceanalytic.com/request-sample/1042
In response to the most recent analysis by InsightAce Analytic, the worldwide Cannabinoid Derived Pharmaceutical market is valued at US$ 636.8 Million in 2021, and it’s anticipated to succeed in US$ 11.2 Billion by 2030, with a CAGR of 37.7{aaa84efcd05d20dc7d0e48929bb8fd8c8895020217096fb46d833d790411cbb9} throughout a forecast interval of 2022-2030.
Hashish crops within the Cannabaceae household produce cannabinoids, additionally known as medicinal marijuana and extensively used pharmaceutical compounds. Because of this, the hashish plant and its derivatives have not too long ago elevated in recognition. Attributable to its pharmacological properties, hashish has functions in treating varied sicknesses and situations, together with diabetes, power ache, arthritis, glaucoma, neurological problems, most cancers, epilepsy, despair, and others. As well as, in comparison with different remedy choices, it’s much less dangerous, has fewer critical uncomfortable side effects, and may also help reduce hostile uncomfortable side effects. Because of this, regardless of various authorized constraints, hashish is accepted for medical utilization in lots of international locations.
Because of the increasing therapeutic functions of cannabinoids in human medication, the exploding use and acceptance of CBD in quite a few international locations, and the rising shopper desire for cannabis-derived merchandise, the cannabinoid-derived pharmaceutical business is anticipated to rise over the forecast interval. The market is additional supported by the increasing commercialization of cannabis-based indications, the enlargement of CBD scientific analysis initiatives, ongoing cannabis-based drug scientific research, and elevating public consciousness of the well being advantages of cannabidiol-containing plant-based items. Nevertheless, the marketplace for CBD merchandise could also be constrained within the coming years on account of inefficient manufacturing strategies and regulatory restrictions on merchandise constructed from hashish in sure international locations.
North America is anticipated to be the key contributor to the Cannabinoid Derived Pharmaceutical market over the forecast years. The revised legalization of hashish for medical use in North America and the rising acceptance of CBD-based merchandise for treating varied medical ailments on this area are the first drivers of market development. As well as, current hashish legal guidelines legalizing cannabinoid merchandise in additional than 23 US states have piqued the curiosity of producers in creating pharmaceutical-derived hashish merchandise to deal with a wide range of scientific issues. As well as, the Asia Pacific Cannabinoid Derived Pharmaceutical market is anticipated to develop considerably in the course of the forecast interval. Elements resembling elevated authorities financing for scientific analysis and the legalization of cannabidiol-derived merchandise would seemingly assist market progress within the Asia Pacific area.
Main market gamers working within the Cannabinoid Derived Pharmaceutical market embody Cara Therapeutics, Inc., Cannabics Prescription drugs Inc., Area Prescription drugs, One World Hashish, Echo Prescription drugs, GW Prescription drugs, LaraPharm, InMed Prescription drugs, INSYS Therapeutics, Inc., MGC Prescription drugs, Ltd., Orpheus Medica, Receptor Life Sciences, RespireRx Prescription drugs, Tetra Bio-Pharma, United Hashish Company, Cardiol Therapeutics, Zynerba Prescription drugs, and Listing of Different Distinguished Gamers.
Latest collaborations and agreements out there:
• In August 2021, the UK Medicines and Healthcare Merchandise Regulatory Company (MHRA) licensed GW Prescription drugs’ EPIDYOLEX (cannabidiol) for the administration of tuberous sclerosis complicated (TSC)-related seizures in individuals two years of age and older (a part of Jazz Prescription drugs plc).
• In Could 2021, Jazz Prescription drugs acquired GW Prescription drugs plc, a enterprise specializing within the examine, creation, and advertising and marketing of prescription medicines primarily based on cannabinoids.
• In December 2021, To create a promising cannabinoid-based therapeutic for intestinal illness, Pfizer entered the medicinal hashish business. Area Prescription drugs, an organization within the scientific levels, was acquired by Pfizer for $6.7 billion.
Inquisitive about this newest model of the report? Acquire Report Particulars @ https://www.insightaceanalytic.com/enquiry-before-buying/1042
Market Segments
International Cannabinoid Derived Pharmaceutical Market, by Merchandise, 2022-2030 (Worth US$ Mn)
• Pure (Plant-derived)
o Epidiolex
o Sativex
o Different Pipeline Merchandise
• Artificial Cannabinoid
o Marinol (Dronabinol)
o Syndros (Dronabinol)
o Cesamet (Nabilone)
o Different Pipeline Merchandise
International Cannabinoid Derived Pharmaceutical Market, by Molecule Kind, 2022-2030 (Worth US$ Mn)
• Cannabinoid Receptor Kind 1 (CB1)
• Cannabinoid Receptor Kind 2 (CB2)
• Others
International Cannabinoid Derived Pharmaceutical Market, by Illness Indication, 2022-2030 (Worth US$ Mn)
• Alzheimer’s Illness
• Autism
• Most cancers
• Power Ache
• Epilepsy
• Migraine
• A number of Sclerosis
• Schizophrenia
• Others
International Cannabinoid Derived Pharmaceutical Market, by Area, 2022-2030 (Worth US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Center East & Africa
North America Cannabinoid Derived Pharmaceutical Market, by Nation, 2022-2030 (Worth US$ Mn)
• U.S.
• Canada
Europe Cannabinoid Derived Pharmaceutical Market, by Nation, 2022-2030 (Worth US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Remainder of Europe
Asia Pacific Cannabinoid Derived Pharmaceutical Market, by Nation, 2022-2030 (Worth US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Cannabinoid Derived Pharmaceutical Market, by Nation, 2022-2030 (Worth US$ Mn)
• Brazil
• Mexico
• Remainder of Latin America
Center East & Africa Cannabinoid Derived Pharmaceutical Market, by Nation, 2022-2030 (Worth US$ Mn)
• GCC Nations
• South Africa
• Remainder of Center East & Africa
Why should purchase this report:
To obtain a complete evaluation of the prospects for the worldwide Cannabinoid Derived Pharmaceutical market
To obtain an business overview and future traits of the Cannabinoid Derived Pharmaceutical market
To investigate the Cannabinoid Derived Pharmaceutical market drivers and challenges
To get data on the Cannabinoid Derived Pharmaceutical market worth (US$Mn) forecast to 2030
Vital investments, mergers & acquisitions within the Cannabinoid Derived Pharmaceutical market business
For Extra Info @ https://www.insightaceanalytic.com/customisation/1042
Priyanka Tilekar
Insightace Analytic Pvt. Ltd.
+1 551-226-6109
e mail us right here
